Holen Sie sich die Stockscreener-App
4.74
1.07%
0.05
Handel nachbörslich:
4.60
-0.14
-2.95%
Schlusskurs vom Vortag:
$4.69
Offen:
$4.61
24-Stunden-Volumen:
4,336
Relative Volume:
0.04
Marktkapitalisierung:
$5.53M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.03M
KGV:
-0.5318
EPS:
-8.9134
Netto-Cashflow:
$-8.20M
1W Leistung:
+1.28%
1M Leistung:
+41.07%
6M Leistung:
-23.67%
1J Leistung:
+33.90%
1-Tages-Spanne:
$4.51
$4.74
1-Wochen-Bereich:
$4.09
$4.7781
52-Wochen-Spanne:
$2.90
$11.96
Endra Life Sciences Inc Stock (NDRA) Company Profile
Firmenname
Endra Life Sciences Inc
Sektor
Branche
Telefon
734-335-0468
Adresse
3600 GREEN COURT, ANN ARBOR, MI
Compare NDRA vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NDRA
Endra Life Sciences Inc
|
4.74 | 5.47M | 0 | -7.03M | -8.20M | -8.9134 |
TMO
Thermo Fisher Scientific Inc
|
488.19 | 182.57B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
192.12 | 135.26B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
577.44 | 45.24B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
114.84 | 32.63B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
304.09 | 29.85B | 3.17B | 642.63M | 516.49M | 10.77 |
Endra Life Sciences Inc Aktie (NDRA) Neueste Nachrichten
ENDRA Life Sciences Inc.Common Stock (NQ: NDRA - FinancialContent
NDRA Stock Price, Quote & Chart | ENDRA LIFE SCIENCES INC (NASDAQ:NDRA) - ChartMill
ENDRA Life Sciences Inc reports results for the quarter ended September 30Earnings Summary - TradingView
ENDRA (NDRA) Optimistic About TAEUS Technology's Potential - gurufocus.com
ENDRA Life Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
ENDRA Life Sciences (NASDAQ: NDRA) flags going-concern risk and pivots to digital asset treasury - Stock Titan
ENDRA Life Sciences | 8-K: ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - Moomoo
ENDRA Life Sciences Q4 net loss narrows - TradingView
ENDRA Life Sciences (NASDAQ: NDRA) cuts 2025 operating costs sharply - Stock Titan
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - Business Wire
Day Trade: Whats the MACD signal for ENDRA Life Sciences Inc2026 Market Overview & Daily Entry Point Alerts - baoquankhu1.vn
Movement Recap: Does ENDRA Life Sciences Inc outperform in volatile marketsWeekly Market Summary & Accurate Entry/Exit Alerts - baoquankhu1.vn
ENDRA Life Sciences (NDRA) Expected to Announce Earnings on Monday - National Today
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
NDRA Ignites: 20% Surge Signals Strategic Overhaul as Capital Hunt for Micro-Cap Alphas - Bitget
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
ENDRA Life Sciences Explores Strategic Alternatives Amid Restructuring - The Globe and Mail
ENDRA Life Sciences explores strategic alternatives By Investing.com - in.investing.com
Speculation Alert: PRSO, ITOC, NDRA, BZAI Small-Cap Momentum Builds – More Names Inside - FinancialContent
ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value - BioSpace
Strategic options review launched by ENDRA Life Sciences (Nasdaq: NDRA) - Stock Titan
ENDRA Life Sciences explores strategic alternatives - Investing.com
ENDRA (NDRA) Explores Strategic Options to Enhance Shareholder V - gurufocus.com
ENDRA Life Sciences Inc. Initiates Review of Strategic Alternatives to Maximize Shareholder Value - marketscreener.com
ENDRA Life Sciences Inc announced that its Board of Directors has initiated a strategic review process aimed at a comprehensive assessment of the company’s future development pathways. - Bitget
ENDRA Life Sciences (NDRA) Expected to Announce Quarterly Earnings on Monday - Defense World
If You Invested $1,000 in Endra Life Sciences Inc (NDRA) - Stock Titan
Tech Rally: Is ENDRA Life Sciences Inc being accumulated by smart money2026 Patterns & Reliable Price Action Trade Plans - baoquankhu1.vn
Stocks Under $10: IBRX, VTIX, NDRA, SMX2026 Watch Now! - openPR.com
Stocks Under $10: IBRX, VTIX, NDRA, SMX – 2026 Watch Now! - The Norfolk Daily News
IBRX, VTIX, NDRA, SMX – 2026 Watch Now! - FinancialContent
ENDRA Life Sciences (NASDAQ: NDRA) - MarketScreener
ENDRA Life Sciences (NASDAQ: NDRA): Medical Diagnostic Play in the $100B+MASH+GLP-1 Healthcare Boom - openPR.com
ENDRA Life Sciences (NASDAQ: NDRA): Medical Diagnostic Play In The $100B+MASH+GLP-1 Healthcare Boom - Mena FN
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
User - The Chronicle-Journal
ENDRA Life Sciences (NASDAQ: NDRA): The GLP-1 Healthcare Boom Offering Tremendous Opportunity Watch HIMS, ANTX, ATAI, PURR Now! - Barchart.com
FinancialContentFavorable Results on Liver Device for Long-Term Monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease Affecting 30% of Adults: ENDRA Life Sciences (Nasdaq: NDRA) - FinancialContent
Strong Clinical Results for Breakthrough Liver Diagnostic Platform; ENDRA Life Sciences (N A S D A Q: NDRA) $NDRA - FinancialContent
Favorable Results on Liver Device for Long-Term Monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease Affecting 30% of Adults: ENDRA Life Sciences (Nasdaq: NDRA) - Barchart
Favorable Results on Liver Device for Long-Term Monitoring - openPR.com
Will ENDRA Life Sciences Inc. stock outperform growth indexesWeekly Trend Summary & Reliable Entry Point Alerts - Naître et grandir
[Form 4] ENDRA Life Sciences Inc. Insider Trading Activity - Stock Titan
NDRA's TAEUS system Reaches MRI-Comparable Accuracy in Liver Imaging - Bitget
NDRA's TAEUS Device Achieves MRI-Level Liver Imaging Precision - TradingView
NDRA Should I Buy - Intellectia AI
NDRA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Stocks in the News: ALBT, NDRA, CURX, HCTIAI, Clinical Milestones Drive Market Surges - marketscreener.com
ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Le - PharmiWeb.com
Endra Life Sciences (NDRA) Announces Positive Trial Results for Liver Device - GuruFocus
ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care - Yahoo Finance
Finanzdaten der Endra Life Sciences Inc-Aktie (NDRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.47%
1.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):